Furthermore, it suppresses LenR HCC cell stemness by activating the JNK/p38 MAPK pathway and inhibiting the NF-κB and NOTCH signaling pathways (Scheme 1). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.